Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Ther Drug Monit. 2015 Oct;37(5):661–669. doi: 10.1097/FTD.0000000000000201

Table 5.

Performance challenge classifications (n=35) at ±25% and ±50% of each evaluated cutoff (5 & 10 µg/L) in each evaluated matrix (Urine & Phosphate Buffered Saline) across 35 plates.

Cutoffs

(µg/L)
JWH-018 N-(5-hydroxypentyl) metabolite

Performance Challenge concentration (µg/L) in urine
Correct classification (%)
2.5 3.75 5.0 6.25 7.5 12.5 15 Negative Positive

−50% −25% +25% +50%
5-PBS 25/35 (−) 5/35 (−) - 34/35 (+) 32/35 (+) - - 71 14 97 91
5-UR 35/35 (−) 30/35 (−) - 24/35 (+) 23/35 (+) - - 100 86 69 66
10-PBS - - 29/35 (−) - 27/35 (−) 33/35 (+) 35/35 (+) 83 77 94 100
10-UR - - 35/35 (−) - 35/35 (−) 34/35 (+) 34/35 (+) 100 100 97 97

(−) = Negative result

(+) = Positive result

PBS = Phosphate Buffered Saline

UR= Urine